Allarity Begins Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Allarity Therapeutics, a Phase 2-stage biopharmaceutical with activities in Copenhagen and Boston, has formally enrolled its first patient in its newly launched Phase 2 trial

New Treatment Aumolertinib Approved for EGFR-Positive NSCLC

Aumolertinib (Aumseqa) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for adult patients with non-small cell lung cancer (NSCLC).

Gland Pharma Received Approval from USFDA for its Blood Pressure Drug

Gland Pharma Limited saw its shares rise nearly 3% during intraday trading on Wednesday following the announcement of a major regulatory accomplishment...

Reckitt & PHFI Unite to Power Next-Gen Public Health Initiatives

Reckitt, the world's leading consumer health and hygiene company, associated with the Public Health Foundation of India

Ayush Exports Gets a Boost as Ayushexcil Joins Official Certifying Agencies

A step in the direction of streamlining and simplification of the export procedure for India's traditional medicinal industry, the Ministry of Commerce and Industry

India to Boost its PLI Initiative for Drug Manufacturing

India is about to give a significant boost to its production-linked incentive (PLI) scheme for pharmaceuticals as it seeks to establish a stronger domestic production of key starting materials (KSMs)...

Zydus to acquire US biotech firm Agenus in Emeryville and Berkeley

Zydus Lifesciences is entering the global biologics contract development and manufacturing (CDMO) arena with its acquisition of two biologics facilities from Agenus at Emeryville and Berkeley in California...

TDB Drives Local Innovation in Complex Pharma Excipients

Indian Technology Development Board (TDB), which operates under Department of Science and Technology (DST), has provided finance support to excipient producer of pharmaceuticals

Indian Pharma Industry Set for Growth Following Fiji's Pharmacopoeia Nod

The Indian Pharmacopoeia (IP) was refurbished to consider as a gold standard and taken to the extent of benchmarking by the Indian Pharmacopoeia Commission

Biocon Received Approval in India for its Liraglutide Drug Substance

Biocon Limited, a global biopharmaceutical company focused on innovation, announced today that its Liraglutide drug substance has been approved in India. In addition, Biocon Pharma Limited, a wholly...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.